Ovid seeks metamorphosis into public company with $86M IPO

This follows on from a fairly quiet start to the year in terms of public offerings from biotech, although just this week Biohaven Pharmaceutical filed to raise up to $100 million in its IPO attempt to … Ovid help out on the Osaka-based company’s …
( read original story …)


Related Post

Tokyo governor’s party heads for big win in ...
views 132
The new party of the Japanese capital's populist g...
SoftBank considers Japan’s biggest ever IPO
views 57
SoftBank said on Monday it was considering listing...
McMaster students touring nuclear disaster site in...
views 104
They are part of the Fukushima Ambassador Program,...
Exploding tablet stops a speeding bullet
views 69
The incident aboard the Nozomi 234 super express t...
Japan Pom Pom – the cheerleading squad for t...
views 115
When Fumie Takino was 63, she started Japan Pom Po...
Nikkei edges up, shares stay on track for weekly g...
views 128
TOKYO, July 14 (Reuters) - Japan's Nikkei share av...
Japan enters uncharted waters as emperor's ab...
views 123
TOKYO (Reuters) - Japan is moving to adopt a law a...
Japan’s lower house of parliament dissolved,...
views 53
Abe stunned Japan on Monday with a surprise call f...
Nagoya Castle’s concrete keep to be demolished and...
views 126
That scenario continued into the 20th century, suc...
DB11 drives Aston Martin back into black in first ...
views 101
They have a whole raft of possibilities, of which ...